Lexatumumab, a targeted antibody, shows significant hope in the treatment against malignant conditions. This innovative drug uniquely binds to the HER3 protein, which is commonly increased in various cancer kinds. https://opensocialfactory.com/story25902417/lexatumumab-a-promising-therapy-for-cancer